Breaking News

ChanTest Opens Expanded Lab Facilities

By Kristin Brooks | March 4, 2014

Adds 50% more capacity for cell and molecular biology services

ChanTest Corp. has expanded capacity by more than 50% for its cellular and molecular services and reagents for drug research at its headquarters in Cleveland, OH. ChanTest scientists use the cells grown in the new facility for ion channel services and products, and for external clients outsourcing cell and molecular work. Examples include standard cell culture services and highly technical custom cell line development projects.
ChanTest's director of Cell & Molecular Biology, Luke Armstrong, Ph.D., said, "Our cell and molecular biology service business nearly doubled in 2013 and we expect another year of strong growth in 2014," said Dr. Armstrong. "The expansion helps ChanTest keep up with the growing needs of our clients."
The new space is fully operational and used for: cell culture labs, adherent cell scale-up of 10 billion cells, controlled rate freezer capable of cryopreserving 600 vials of cells, membrane preparations of up to 2 grams of protein, large-scale electroporator capable of generating three billion transfected cells, flow sorter (FACSAria), dedicated molecular biology lab, and radioisotope lab.

Related Packaging:

blog comments powered by Disqus
  • Setting Health-Based Exposure Limits to Support Pharmaceutical Development and Manufacturing

    Setting Health-Based Exposure Limits to Support Pharmaceutical Development and Manufacturing

    B.D. Naumann, P.J. Nigro, U. Bruen, L. Parola, D. Cragin and A. Schatz, Merck & Co., Inc. and Ashland, Inc.||May 5, 2016
    Health-based exposure limits are needed to support risk assessments

  • Solid Dispersions

    Solid Dispersions

    Robert Harris, Juniper Pharma Services||April 5, 2016
    A universal formulation strategy for poorly soluble drugs?

  • Fit-For-Purpose Assay Development in Bioanalysis

    Fit-For-Purpose Assay Development in Bioanalysis

    Franklin Spriggs, Ligand Binding Assay Group Leader; Ashley Brant, Program Manager, AIT Bioscience||January 28, 2016
    The success of bioanalytical studies relies on the selection of the most suitable analytical method but the timeline of method development and types of analyses involved vary greatly.